About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Maryland | 303 Studies

Clinical Trials MelanomaMaryland

Melanoma Clinical Trials in Maryland

Find 303 clinical trials for melanoma near Maryland. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 303 trials

Not yet recruitingMirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young AdultsBackground: Large and giant congenital melanocytic nevi (LGCMN) are dark birthmarks (moles). They can grow to 8 inches or more across.NCT07891286·Bethesda, Maryland CompletedCancer Risk in Carriers of the Gene for Xeroderma PigmentosumThis study will determine if family members of patients with xeroderma pigmentosum (XP) have various abnormalities, including: skin abnormalities; nervous system abnormalities…NCT00046189·Bethesda, Maryland

Melanoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS0008: Chemotherapy Plus Biological Therapy in Treating Patients With MelanomaRATIONALE: Interferon alfa may interfere with the growth of cancer cells.NCT00006237·Birmingham, Alabama and 296 others

CompletedCyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic MelanomaRATIONALE: Inserting a laboratory-treated gene into a person's white blood cells may make the body build an immune response to kill tumor cells.NCT00091104·Bethesda, Maryland and 1 other

CompletedBehavioral Weight Loss Program for Cancer Survivors in MarylandBehavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration ProjectNCT04534309·Baltimore, Maryland

TerminatedMessenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous CancerBackground: Exome sequencing can identify certain gene mutations in a person's tumor. This can then be used to create cancer treatments.NCT03480152·Bethesda, Maryland

TerminatedChemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic CancerBackground: -This study uses an experimental cancer treatment that uses the patient s own lymphocytes (type of white blood cell), which are specially selected and genetically…NCT00670748·Bethesda, Maryland

RecruitingThe Cancer of the Pancreas Screening-5 CAPS5)StudyJohns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins.NCT02000089·New Haven, Connecticut and 8 others

CompletedBiological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney CancerRATIONALE: Biological therapies such as flt3L and CD40-ligand use different ways to stimulate the immune system and stop cancer cells from growing.NCT00020540·Bethesda, Maryland

TerminatedHD IL-2 + Ipilimumab in Patients With Metastatic MelanomaPhase IV, open-label, randomized, two-arm, multi-center study in patients with metastatic melanoma who are treatment naïve or have previously received a single non-immunologic…NCT01856023·Tucson, Arizona and 11 others

TerminatedComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryThis phase III trial compares the effect of adding whole brain radiotherapy with hippocampal avoidance and memantine versus stereotactic radiosurgery alone in treating patients…NCT04588246·Tucson, Arizona and 80 others

TerminatedCell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating LymphocytesBackground: \- One experimental treatment for certain types of cancer is cell therapy, which involves collecting lymphocytes (white blood cells) from a tumor, growing them in the…NCT01236573·Bethesda, Maryland

Active not recruitingTesting the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerThis phase I trial studies the side effects and best dose of ziv-aflibercept when given together with pembrolizumab in treating patients with solid tumors that that may have…NCT02298959·Tampa, Florida and 8 others

TerminatedBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated MelanomaThe primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay…NCT03727087·Little Rock, Arkansas and 35 others

RecruitingAssessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsThis is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are…NCT06418204·Fairbanks, Alaska and 490 others

CompletedA Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid TumorsBackground GD2 is a well-characterized tumor antigen in neuroblastoma, which is also expressed on osteosarcomas and some other sarcomas.NCT02107963·Bethesda, Maryland

AvailableExpanded Access Program of AMTAGVI That is Out of Specification for Commercial ReleaseThe objective of this expanded access protocol is to provide access to Out Of Specification (OOS) AMTAGVI treatment to patients.NCT05398640·Gilbert, Arizona and 47 others

CompletedCD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With NivolumabThis study is a Phase 1-2 open-label dose escalation study of the immuno-activating monoclonal antibody APX005M administered in combination with nivolumab to adult subjects with…NCT03123783·Tucson, Arizona and 22 others

TerminatedA Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaThe purpose of this phase 2 study is to evaluate the efficacy and safety of NIR178 in combination with PDR001 in multiple solid tumors and diffuse large B-cell lymphoma (DLBCL)…NCT03207867·Santa Monica, California and 20 others

Active not recruitingStudy Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced MelanomaThis is a clinical study to compare the efficacy and safety of HBI-8000 combined with nivolumab to Placebo combined with nivolumab in patients with unresectable or metastatic…NCT04674683·Bakersfield, California and 138 others

PreviousPage 4 of 16Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma